There are a lot of ASX shares for investors to choose from on the Australian share market.
But which ASX 200 shares could be top picks right now for a $2,000 investment? Let's take a look at two that analysts are bullish on. They are as follows:
Image source: Getty Images
WiseTech Global Ltd (ASX: WTC)
The first ASX 200 share that could be a buy is WiseTech Global. It is a leading provider of logistics solutions software that helps power international supply chains.
Its key offering is CargoWise, which is a cloud-based, integrated software platform that provides a comprehensive suite of tools for managing various aspects of logistics operations. This includes freight forwarding, customs and compliance, and warehouse management.
Bell Potter is a fan of the company and remains very positive on its outlook. And with its shares trading on attractive multiples compared to peers, it thinks now could be the time to invest.
The broker notes that "WiseTech and Technology One trade on similar FY26 EV/EBITDA multiples and PE ratios and in our view WiseTech deserves to trade on a premium given its superior growth outlook." It also feels that "the premium will return, particularly if both the CTO launch and e2open acquisition are successful."
Bell Potter currently has a buy rating and $135.00 price target on WiseTech Global's shares.
Xero Ltd (ASX: XRO)
Another ASX 200 share that analysts have named as a buy is Xero.
It is a cloud accounting platform provider that connects small business owners with their numbers, their bank, and advisors at any time. The company currently has over 4.4 million subscribers globally, which is generating significant recurring revenue and earnings.
The good news is that the team at Macquarie believes that Xero's subscriber growth will continue. Particularly given the recent announcement of the acquisition of Melio, which is expected to supercharge its US business.
The broker highlights that "Melio improves XRO's ability to grow in the US, XRO's largest TAM segment at US$29b. Medium-term, the larger risk to XRO is an inability to deliver on US growth, not accretion/dilution on a 1/2 year forward time horizon. This acquisition [shores] up the 5-10 year growth story."
It also notes that "Mgmt is walking the walk, making data-driven decisions that invariably lead to better capital allocation outcomes. We have high conviction in >12- month story."
Macquarie currently has an outperform rating and $204.00 price target on Xero's shares.
